Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | CA2 | P00918 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | EGFR | P00533 | 2/20 | 0.45 |
| ▸ | FYN | P06241 | 2/20 | 0.45 |
| ▸ | MMP9 | P14780 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30368089 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL9327128 | 0.86 | ALDH1A1 (0.71) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL28056463 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| Benzoic Acid SCHEMBL27652235 | 0.84 | TSHR (0.52) | ALDH1A1TDP1TSHRCA2CYP3A4 | |
| SCHEMBL29506834 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL2059781 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| Tert-Butanol SCHEMBL27621850 | 0.82 | ALDH1A1 (0.90) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL11796471 | 0.82 | ALDH1A1 (0.65) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL11813237 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1TSHRCA2ALOX15 | |
| SCHEMBL584830 | 0.81 | ALDH1A1 (0.71) | ALDH1A1TDP1TSHRCA2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119859118-A | Synthesis method of 4- (2-hydroxy-2-propyl) cumene hydroperoxide | 中国石油化工股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-26 | — | — | US | disclosed |
| CN-110531580-B | Chemically amplified negative resist composition and resist pattern forming method | 信越化学工业株式会社 | 2023-08-29 | — | — | CN | disclosed |
| EP-3964509-B1 | COMPOUND CONTAINING FUSED RING, USE THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | NANJING HEPO PHARMACEUTICAL CO LTD (CN) | 2023-06-14 | — | — | EP | disclosed |
| US-11661420-B2 | Compound containing fused ring, use thereof and pharmaceutical composition containing same | NANJING HEPO PHARMACEUTICAL CO., LTD (CN) | 2023-05-30 | — | — | US | disclosed |
| US-11661420-B2 | Compound containing fused ring, use thereof and pharmaceutical composition containing same | NANJING HEPO PHARMACEUTICAL CO., LTD (CN) | 2023-05-30 | — | — | US | disclosed |
| US-11572430-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-02-07 | — | — | US | disclosed |
| CN-110526802-B | Monomer, polymer, negative resist composition, photomask blank, and resist pattern forming method | 信越化学工业株式会社 | 2022-09-20 | — | — | CN | disclosed |
| US-20220213085-A1 | COMPOUND CONTAINING FUSED RING, USE THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | NANJING HEPO PHARMACEUTICAL CO., LTD (CN) | 2022-07-07 | — | — | US | disclosed |
| US-11243467-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-02-08 | — | — | US | disclosed |
| US-5374629-A | A triene steroids as anticarcinogenic agents, treating skin disorders | LEO PHARMACEUTICAL PRODUCTS LTD. A/S LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB (DK) | 1994-12-20 | — | — | US | disclosed |
| EP-0522013-B1 | NOVEL VITAMIN D ANALOGUES | LEO PHARM PROD LTD (DK) | 1994-11-23 | — | — | EP | disclosed |
| EP-0522013-A1 | NOVEL VITAMIN D ANALOGUES. | LEO PHARM PROD LTD (DK) | 1993-01-13 | — | — | EP | disclosed |
| WO-1991015475-A1 | NOVEL VITAMIN D ANALOGUES | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) | 1991-10-17 | — | — | WO | disclosed |
| US-4978789-A | CATALYTIC DEHYDROGENATION USING A MIXED OXIDE CONTAINING IRON AND SILICON; DEALKENYLATION OF ALKYL PHENOLS AND ANILINES | MITSUI CHEMICALS, INC. (JP) | 1990-12-18 | — | — | US | disclosed |
| EP-0205317-B1 | PROCESS FOR PRODUCTION OF ALKENYL SUBSTITUTED AROMATIC COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0205317-A1 | Process for production of alkenyl substituted aromatic compound | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1986-12-17 | — | — | EP | disclosed |
| US-4258219-A | Process for producing hydroquinone | MITSUI TOATSU CHEMICALS, INC. (JP) | 1981-03-24 | — | — | US | disclosed |
| US-4230890-A | PRECIPITATION BY TREATING AN ORGANIC SOLUTION OF HYDROCARBON OXIDATES WITH AN ALKALI METAL HYDROXIDE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-3969420-A | Process for recovering resorcinol and hydroquinone in mixture | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11852970-B2 | Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin | SLC39A11, CROCC, TERB1 | ALDH1A1 3830/4885TDP1 2867/4885TSHR 2912/4885 |
| US-11572430-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | C9, C5, C1R | ALDH1A1 1540/4885TDP1 3114/4885TSHR 1292/4885 |
| US-11243467-B2 | Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method | C9, C5, C1R | ALDH1A1 1540/4885TDP1 3114/4885TSHR 1292/4885 |
| US-20220213085-A1 | COMPOUND CONTAINING FUSED RING, USE THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | HLA-B, HLA-A, SLC10A1 | ALDH1A1 2801/4885TDP1 3430/4885TSHR 3525/4885 |
| US-11661420-B2 | Compound containing fused ring, use thereof and pharmaceutical composition containing same | HLA-B, HLA-A, SLC10A1 | ALDH1A1 2801/4885TDP1 3430/4885TSHR 3525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.